Elevation Oncology, Inc.
CIK 0001783032
Revenue (TTM)
—
Q1 May 2025
Net Income (TTM)
−$48.26M
+2.7% YoY
Q1 May 2025
EPS Diluted (TTM)
−$0.86
+37.6% YoY
Q1 May 2025
Gross Margin
—
Q1 May 2025
Operating Margin
—
Q1 May 2025
Net Margin
—
Q1 May 2025
Free Cash Flow (TTM)
−$53.14M
Q1 May 2025
Cash
$60.49M
Q1 May 2025
Total Debt
$31.25M
Q1 May 2025
Shares Outstanding
59.22M sh
Q1 May 2025
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.